HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Issue 7 (July 2021)
- Record Type:
- Journal Article
- Title:
- HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Issue 7 (July 2021)
- Main Title:
- HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study
- Authors:
- Laurent, Christian
Dembélé Keita, Bintou
Yaya, Issifou
Le Guicher, Gwenvael
Sagaon-Teyssier, Luis
Agboyibor, Mawuényégan K
Coulibaly, Alou
Traoré, Issa
Malan, Jean-Baptiste
De Baetselier, Irith
Eubanks, August
Riegel, Lucas
Rojas Castro, Daniela
Fayé-Ketté, Hortense
Koné, Amadou
Diandé, Souba
Dagnra, Claver A
Serrano, Laetitia
Diallo, Fodié
Mensah, Ephrem
Dah, Ter Tiero E
Anoma, Camille
Vuylsteke, Bea
Spire, Bruno
Laurent, Christian
Yaya, Issifou
Ouedraogo, Sayouba
Granouillac, Bruno
Le Guicher, Gwenvael
Serrano, Laetitia
Peeters, Martine
Couderc, Clotilde
Spire, Bruno
Sagaon-Teyssier, Luis
Mora, Marion
Maradan, Gwenaëlle
Bourrelly, Michel
Mimi, Mohamed
Berenger, Cyril
Boyer, Sylvie
Rojas Castro, Daniela
Riegel, Lucas
Palvadeau, Paméla
Vuylsteke, Bea
De Baetselier, Irith
Reyniers, Thijs
Dembélé Keita, Bintou
Diallo, Fodié
Coulibaly, Alou
Maïga, Alassane Kader
Camara, Drissa
Diarra, Mahamadou
Ouologuem, Aly
Sangaré, Naboh
Keita, Abdoul Aziz
Cissé, Oumar
Traoré, Fodé
Ouary, Bréhima Abdrahamane
Kanta, Ibrahima
Anoma, Camille
Malan, Jean-Baptiste
Kotchi, Rachelle
Aka, Niamkey Thomas
Lokrou, Kpassou Julien
Coulibaly, Noufo Hamed
Koffi, Ekissi Jean Armel
N'guessan, Dibi Frédéric
Babo Yoro, Stéphane-Alain
Cissé, Adama
Dah, Ter Tiero Elias
Traoré, Issa
Rajaonarivelo, Camille
Ouedraogo, Fayçal Rodrique
Ouedraogo, Joseph
Coulibaly, Christian
Ouedraogo, Mamadou
Ilboudo, Ousseni
Traoré, Abdoulazziz
Comsiambo, Honoré
Mensah, Ephrem
Agboyibor, Mawuényégan Kouamivi
Attisso, Anani
Kokouba, Anouwarsadat
Badjassim, Aléda Mawuli
Agbomadji, Kouakou Kokouvi Selom
Attiogbe, Messan
Yaka, Kossi Jeff
Ekon, Agbégnigan Lorette
Bimba, Julien
Dagnra, Claver Anoumou
Tegueni, Kokou Dominique
… (more) - Abstract:
- Summary: Background: HIV pre-exposure prophylaxis (PrEP) data in men who have sex with men (MSM) in west Africa are essential to guide its large-scale implementation. We assessed the uptake of event-driven and daily PrEP, HIV incidence, and changes over time in sexual behaviours and prevalence of bacterial sexually transmitted infections (STIs) in MSM in Burkina Faso, Côte d'Ivoire, Mali, and Togo. Methods: We did a prospective cohort study from Nov 20, 2017, to April 14, 2020, in four community-based clinics in Abidjan (Côte d'Ivoire), Bamako (Mali), Lomé (Togo), and Ouagadougou (Burkina Faso). Participants were MSM aged 18 years or older at substantial risk of HIV infection. Participants could choose between event-driven (2+1+1 dosing) and daily oral PrEP (tenofovir disoproxil fumarate 300 mg plus emtricitabine 200 mg), switch regimen, and discontinue or restart PrEP. We compared HIV incidence in this study with that of the same cohort before the availability of PrEP (CohMSM). Statistical analysis included the Kaplan-Meier method and mixed-effects regression models. This study is registered with ClinicalTrials.gov, NCT03459157 . Findings: We followed up 598 participants for a total of 743·6 person-years. At enrolment, 445 (74%) of 598 participants chose event-driven PrEP and 153 (26%) of 598 chose daily PrEP. 60 (13%) of 445 and 65 (42%) of 153 participants switched PrEP regimen at least once (p<0·0001). 159 participants (27%) were lost to follow-up. Overall HIV incidenceSummary: Background: HIV pre-exposure prophylaxis (PrEP) data in men who have sex with men (MSM) in west Africa are essential to guide its large-scale implementation. We assessed the uptake of event-driven and daily PrEP, HIV incidence, and changes over time in sexual behaviours and prevalence of bacterial sexually transmitted infections (STIs) in MSM in Burkina Faso, Côte d'Ivoire, Mali, and Togo. Methods: We did a prospective cohort study from Nov 20, 2017, to April 14, 2020, in four community-based clinics in Abidjan (Côte d'Ivoire), Bamako (Mali), Lomé (Togo), and Ouagadougou (Burkina Faso). Participants were MSM aged 18 years or older at substantial risk of HIV infection. Participants could choose between event-driven (2+1+1 dosing) and daily oral PrEP (tenofovir disoproxil fumarate 300 mg plus emtricitabine 200 mg), switch regimen, and discontinue or restart PrEP. We compared HIV incidence in this study with that of the same cohort before the availability of PrEP (CohMSM). Statistical analysis included the Kaplan-Meier method and mixed-effects regression models. This study is registered with ClinicalTrials.gov, NCT03459157 . Findings: We followed up 598 participants for a total of 743·6 person-years. At enrolment, 445 (74%) of 598 participants chose event-driven PrEP and 153 (26%) of 598 chose daily PrEP. 60 (13%) of 445 and 65 (42%) of 153 participants switched PrEP regimen at least once (p<0·0001). 159 participants (27%) were lost to follow-up. Overall HIV incidence was 2·3 per 100 person-years (95% CI 1·3–3·7; adjusted incidence rate ratio 0·21, 95% CI 0·12–0·36 compared with CohMSM). Adherence was optimal in 802 (41%) of 1946 measures with event-driven PrEP and in 394 (71%) of 554 measures with daily PrEP (p<0·0001). Coverage of sex acts with PrEP only and PrEP and condom decreased during follow-up (p=0·039 if PrEP only; p=0·0025 if PrEP and condom). The frequency of condomless anal sex remained stable (p=0·96). The number of male sexual partners (p<0·0001) and number of sex acts with casual male partners (p=0·0014 for 1–4 sex acts in previous 4 weeks; p=0·030 for ≥5 sex acts) decreased. The prevalence of gonorrhoea, chlamydia, and syphilis remained stable. Interpretation: PrEP availability helped prevent HIV infection and did not lead to an increase in risky sexual behaviours or other STIs. PrEP should be urgently implemented in west Africa. Retention in care and PrEP adherence require special attention to ensure PrEP reaches its full prevention potential. Funding: ANRS and Expertise France. Translation: For the French translation of the abstract see Supplementary Materials section. … (more)
- Is Part Of:
- Lancet. Volume 8:Issue 7(2021)
- Journal:
- Lancet
- Issue:
- Volume 8:Issue 7(2021)
- Issue Display:
- Volume 8, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 8
- Issue:
- 7
- Issue Sort Value:
- 2021-0008-0007-0000
- Page Start:
- e420
- Page End:
- e428
- Publication Date:
- 2021-07
- Subjects:
- HIV (Viruses) -- Periodicals
HIV infections -- Periodicals
AIDS (Disease) -- Periodicals
616.9792 - Journal URLs:
- http://www.sciencedirect.com/science/journal/23523018 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/S2352-3018(21)00005-9 ↗
- Languages:
- English
- ISSNs:
- 2405-4704
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.081570
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17421.xml